VTR Ventas Inc.

Ventas Earns Nareit 2024 Healthcare “Leader in the Light” Award

Ventas, Inc. (NYSE: VTR) today announced that it has earned the 2024 Nareit “Leader in the Light” award for the Healthcare sector in recognition of its superior and longstanding sustainability practices. This is the eighth time Ventas has received this important recognition.

In addition, Ventas was recognized with Nareit’s inaugural “Impact at Scale” award for the Company’s innovative and scalable approach to decarbonization. As part of its commitment to achieving net zero operations, Ventas used machine learning and physics-based modeling to efficiently create property-specific decarbonization roadmaps for each of the more than 800 properties under the Company’s operational control. In 2022, Ventas became the first healthcare REIT to commit to net zero operational carbon emissions (Scopes 1 + 2), which it plans to achieve by 2040.

“We’re proud to be recognized for our steadfast commitment to sustainability and rigorous, data-driven approach to advancing goals that strengthen our business and drive value for residents, tenants, caregivers and shareholders," said Kelly Meissner, Ventas Vice President, Corporate ESG & Sustainability. “As a major participant in the longevity economy, our work is more essential to society than ever before. Our sustainability efforts build value for all our stakeholders and advance our mission to help people live longer, healthier, happier lives.”

Nareit’s annual Leader in the Light Awards recognize REITs that demonstrate leadership in implementing sustainable and socially responsible investment and operating practices, good governance and transparency. The awards were presented to Nareit corporate members in nine property sector categories.

Nareit’s inaugural Sustainability Impact Awards, including the “Impact at Scale” award, recognize REITs for implementing sustainable practices that demonstrate leadership, ingenuity and environmental impact in the commercial real estate industry.

Ventas is a widely recognized industry leader in sustainability. Additional recent achievements include:

  • #1 Listed Healthcare REIT in the GRESB global ESG real estate assessment since 2017
  • ENERGY STAR ® Partner of the Year in Energy Management for 4th consecutive year with Sustained Excellence designation for 2nd consecutive year
  • Maintained ISS ESG Prime Status for Corporate ESG performance since 2020
  • America’s Most Responsible Companies list by Newsweek for the 4th consecutive year
  • Top-Rated ESG Regional Company by Morningstar Sustainalytics for the 2nd consecutive year

Ventas’s 2023-2024 Corporate Sustainability Report (“CSR”) details the Company’s sustainability initiatives to support the growth and success of its business and to advance the Company’s vital mission of helping a large and rapidly growing aging population live longer, healthier, happier lives. The CSR is available at .

About Ventas

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,350 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its over 800 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company aims to deliver outsized performance by leveraging its unmatched operational expertise, data-driven insights from its Ventas OI™ platform, extensive relationships and strong financial position. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

EN
20/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ventas Inc.

Jay Kornreich ... (+2)
  • Jay Kornreich
  • Richard Anderson
Wedbush Research
  • Wedbush Research
UBI UBISOFT ENTERTAINMENT SA
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.
 PRESS RELEASE

Ventas to Participate in Investor Meetings at Citi 2025 Global Propert...

CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation at the Citi 2025 Global Property CEO Conference (the “Citi Conference”) on March 4, 2025 at 1:30 p.m. Eastern Time. The webcast will be accessible on the Company’s website at . Any Company written materials accompanying the presentation at the Citi Conference will be available on the Company’s website on or about March 3, 2025. These materials and a replay of the webcast will be archived at for a limited period following the event. About Ventas Ventas,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch